Statistics for the Plotted Points |
TERBUTHYLAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 104% | 14% | 107% | 10% |
Total | 45 | 104% | 14% | 107% | 10% |
Miscellaneous Statistics for the Samples |
TERBUTHYLAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 22 | . | |
False Positives | 0 | 0% | 0 out of 22 |
Statistics for the Plotted Points |
HEXAZINONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 43 | 70% | 21% | 71% | 19% |
Total | 43 | 70% | 21% | 71% | 19% |
Miscellaneous Statistics for the Samples |
HEXAZINONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 25 | . | |
False Positives | 0 | 0% | 0 out of 24 |
Statistics for the Plotted Points |
SIMAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 95% | 15% | 97% | 12% |
Total | 40 | 95% | 15% | 97% | 12% |
Miscellaneous Statistics for the Samples |
SIMAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 28 | . | |
False Positives | 11 | 41% | 11 out of 27 |
Statistics for the Plotted Points |
PROMETRYN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 99% | 16% | 100% | 10% |
Total | 44 | 99% | 16% | 100% | 10% |
Miscellaneous Statistics for the Samples |
PROMETRYN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 23 | . | |
False Positives | 0 | 0% | 0 out of 23 |
Statistics for the Plotted Points |
PROMETON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 99% | 15% | 101% | 14% |
Total | 40 | 99% | 15% | 101% | 14% |
Miscellaneous Statistics for the Samples |
PROMETON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 28 | . | |
False Positives | 0 | 0% | 0 out of 27 |
Statistics for the Plotted Points |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 45% | 12% | 45% | 8% |
Total | 40 | 45% | 12% | 45% | 8% |
Miscellaneous Statistics for the Samples |
DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 40 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 28 | . | |
False Positives | 2 | 7% | 2 out of 27 |
Statistics for the Plotted Points |
FONOFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 85% | 15% | 85% | 13% |
Total | 34 | 85% | 15% | 85% | 13% |
Miscellaneous Statistics for the Samples |
FONOFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 35 | . | |
False Positives | 1 | 3% | 1 out of 33 |
Statistics for the Plotted Points |
DICROTOPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 39% | 13% | 34% | 15% |
>= Reporting Level | 18 | 21% | 6% | 20% | 8% |
Total | 29 | 28% | 13% | 27% | 10% |
Miscellaneous Statistics for the Samples |
DICROTOPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 29 | 97% | Spiked |
Estimated Values | 29 | 97% | Spiked |
Deleted Values | 4 | 6% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 1 | 3% | 1 out of 30 |
Not Spiked | 39 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
DICHLOROVOS (DICHLORVOS) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 43% | 17% | 41% | 20% |
Total | 45 | 43% | 17% | 41% | 20% |
Miscellaneous Statistics for the Samples |
DICHLOROVOS (DICHLORVOS) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 45 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 22 | . | |
False Positives | 0 | 0% | 0 out of 22 |
Statistics for the Plotted Points |
CHLORPYRIFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 43 | 94% | 12% | 97% | 13% |
Total | 43 | 94% | 12% | 97% | 13% |
Miscellaneous Statistics for the Samples |
CHLORPYRIFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 26 | . | |
False Positives | 0 | 0% | 0 out of 24 |
Statistics for the Plotted Points |
DIELDRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 102% | 19% | 100% | 16% |
Total | 35 | 102% | 19% | 100% | 16% |
Miscellaneous Statistics for the Samples |
DIELDRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 33 | . | |
False Positives | 0 | 0% | 0 out of 32 |
Statistics for the Plotted Points |
METOLACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 101% | 15% | 103% | 16% |
Total | 40 | 101% | 15% | 103% | 16% |
Miscellaneous Statistics for the Samples |
METOLACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 28 | . | |
False Positives | 0 | 0% | 0 out of 27 |
Statistics for the Plotted Points |
MALATHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 72% | 32% | 69% | 47% |
>= Reporting Level | 44 | 73% | 26% | 77% | 25% |
Total | 47 | 73% | 26% | 76% | 26% |
Miscellaneous Statistics for the Samples |
MALATHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 47 | 98% | Spiked |
Estimated Values | 4 | 8% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 49 | . | |
False Negatives | 1 | 2% | 1 out of 48 |
Not Spiked | 20 | . | |
False Positives | 0 | 0% | 0 out of 19 |
Statistics for the Plotted Points |
DIAZINON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 96% | 14% | 96% | 11% |
Total | 39 | 96% | 14% | 96% | 11% |
Miscellaneous Statistics for the Samples |
DIAZINON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 29 | . | |
False Positives | 0 | 0% | 0 out of 28 |
Statistics for the Plotted Points |
ATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 104% | 12% | 105% | 9% |
Total | 45 | 104% | 12% | 105% | 9% |
Miscellaneous Statistics for the Samples |
ATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 22 | . | |
False Positives | 1 | 5% | 1 out of 22 |
Statistics for the Plotted Points |
ALACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 96% | 15% | 100% | 14% |
Total | 40 | 96% | 15% | 100% | 14% |
Miscellaneous Statistics for the Samples |
ALACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 28 | . | |
False Positives | 0 | 0% | 0 out of 27 |
Statistics for the Plotted Points |
ACETOCHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 100% | 17% | 102% | 13% |
Total | 44 | 100% | 17% | 102% | 13% |
Miscellaneous Statistics for the Samples |
ACETOCHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 23 | . | |
False Positives | 0 | 0% | 0 out of 23 |
Statistics for the Plotted Points |
1-NAPHTHOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 19 | 29% | 18% | 24% | 22% |
>= Reporting Level | 23 | 26% | 25% | 17% | 29% |
Total | 42 | 28% | 22% | 21% | 24% |
Miscellaneous Statistics for the Samples |
1-NAPHTHOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 93% | Spiked |
Estimated Values | 42 | 93% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 47 | . | |
False Negatives | 2 | 4% | 2 out of 45 |
Not Spiked | 22 | . | |
False Positives | 12 | 55% | 12 out of 22 |
Statistics for the Plotted Points |
CYFLUTHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 70% | 17% | 73% | 8% |
>= Reporting Level | 27 | 54% | 21% | 49% | 16% |
Total | 32 | 56% | 21% | 50% | 21% |
Miscellaneous Statistics for the Samples |
CYFLUTHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 32 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 36 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
CYPERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 53% | 23% | 46% | 17% |
Total | 30 | 53% | 23% | 46% | 17% |
Miscellaneous Statistics for the Samples |
CYPERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 100% | Spiked |
Estimated Values | 30 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 0 | 0% | 0 out of 30 |
Not Spiked | 39 | . | |
False Positives | 0 | 0% | 0 out of 37 |
Statistics for the Plotted Points |
FENAMIPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 103% | 38% | 112% | 55% |
>= Reporting Level | 29 | 77% | 25% | 72% | 23% |
Total | 32 | 79% | 27% | 74% | 25% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 3 | 9% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 36 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
IPRODIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 52% | 17% | 51% | 19% |
>= Reporting Level | 26 | 79% | 41% | 73% | 41% |
Total | 37 | 71% | 37% | 68% | 28% |
Miscellaneous Statistics for the Samples |
IPRODIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 97% | Spiked |
Estimated Values | 37 | 97% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 38 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 29 |
Statistics for the Plotted Points |
ISOFENPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 37 | 92% | 19% | 93% | 17% |
Total | 37 | 92% | 19% | 93% | 17% |
Miscellaneous Statistics for the Samples |
ISOFENPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 37 | . | |
False Negatives | 0 | 0% | 0 out of 37 |
Not Spiked | 32 | . | |
False Positives | 0 | 0% | 0 out of 30 |
Statistics for the Plotted Points |
METALAXYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 46 | 99% | 15% | 100% | 11% |
Total | 46 | 99% | 15% | 100% | 11% |
Miscellaneous Statistics for the Samples |
METALAXYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 48 | . | |
False Negatives | 0 | 0% | 0 out of 46 |
Not Spiked | 21 | . | |
False Positives | 0 | 0% | 0 out of 21 |
Statistics for the Plotted Points |
METHIDATHION (SUPRACIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 90% | 19% | 89% | 23% |
Total | 30 | 90% | 19% | 89% | 23% |
Miscellaneous Statistics for the Samples |
METHIDATHION (SUPRACIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 0 | 0% | 0 out of 30 |
Not Spiked | 39 | . | |
False Positives | 0 | 0% | 0 out of 37 |
Statistics for the Plotted Points |
MYCLOBUTANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 89% | 15% | 87% | 17% |
Total | 45 | 89% | 15% | 87% | 17% |
Miscellaneous Statistics for the Samples |
MYCLOBUTANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 22 | . | |
False Positives | 0 | 0% | 0 out of 22 |
Statistics for the Plotted Points |
PHOSMET (IMIDAN) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 14 | 38% | 17% | 38% | 12% |
Total | 14 | 38% | 17% | 38% | 12% |
Miscellaneous Statistics for the Samples |
PHOSMET (IMIDAN) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 14 | 54% | Spiked |
Estimated Values | 14 | 54% | Spiked |
Deleted Values | 15 | 22% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 12 | 46% | 12 out of 26 |
Not Spiked | 39 | . | |
False Positives | 0 | 0% | 0 out of 28 |
Statistics for the Plotted Points |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 8 | 73% | 19% | 77% | 16% |
Total | 8 | 73% | 19% | 77% | 16% |
Miscellaneous Statistics for the Samples |
TRIBUFOS (S,S,S-TRIBUTYLPHOSPHOROTRITHIOATE (DEF)) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 8 | 100% | Spiked |
Estimated Values | 8 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 8 | . | |
False Negatives | 0 | 0% | 0 out of 8 |
Not Spiked | 4 | . | |
False Positives | 0 | 0% | 0 out of 4 |
Statistics for the Plotted Points |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 97% | 14% | 97% | 14% |
Total | 44 | 97% | 14% | 97% | 14% |
Miscellaneous Statistics for the Samples |
2-CHLORO-2,6-DIETHYLACETANILIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 24 | . | |
False Positives | 0 | 0% | 0 out of 23 |
Statistics for the Plotted Points |
2-ETHYL-6-METHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 91% | 10% | 93% | 8% |
Total | 32 | 91% | 10% | 93% | 8% |
Miscellaneous Statistics for the Samples |
2-ETHYL-6-METHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 32 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 36 | . | |
False Positives | 4 | 11% | 4 out of 35 |
Statistics for the Plotted Points |
3,4-DICHLOROANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 75% | 12% | 77% | 7% |
Total | 45 | 75% | 12% | 77% | 7% |
Miscellaneous Statistics for the Samples |
3,4-DICHLOROANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 24 | 53% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 22 | . | |
False Positives | 0 | 0% | 0 out of 21 |
Statistics for the Plotted Points |
4-CHLORO-2-METHYLPHENOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 38 | 52% | 10% | 54% | 9% |
Total | 38 | 52% | 10% | 54% | 9% |
Miscellaneous Statistics for the Samples |
4-CHLORO-2-METHYLPHENOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 100% | Spiked |
Estimated Values | 38 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 0 | 0% | 0 out of 38 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 29 |
Statistics for the Plotted Points |
AZINPHOS-METHYL-OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 90% | . | 90% | 0% |
>= Reporting Level | 10 | 54% | 20% | 49% | 19% |
Total | 11 | 57% | 22% | 51% | 30% |
Miscellaneous Statistics for the Samples |
AZINPHOS-METHYL-OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 11 | 79% | Spiked |
Estimated Values | 11 | 79% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 1 | 7% | Spiked |
Spiked | 14 | . | |
False Negatives | 2 | 14% | 2 out of 14 |
Not Spiked | 55 | . | |
False Positives | 0 | 0% | 0 out of 53 |
Statistics for the Plotted Points |
CHLORPYRIFOS, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 36% | 9% | 31% | 11% |
>= Reporting Level | 22 | 27% | 10% | 24% | 7% |
Total | 27 | 28% | 10% | 26% | 10% |
Miscellaneous Statistics for the Samples |
CHLORPYRIFOS, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 87% | Spiked |
Estimated Values | 27 | 87% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 4 | 13% | 4 out of 31 |
Not Spiked | 37 | . | |
False Positives | 0 | 0% | 0 out of 36 |
Statistics for the Plotted Points |
DIAZINON, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 17 | 58% | 21% | 52% | 16% |
Total | 17 | 58% | 21% | 52% | 16% |
Miscellaneous Statistics for the Samples |
DIAZINON, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 17 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 17 | . | |
False Negatives | 0 | 0% | 0 out of 17 |
Not Spiked | 11 | . | |
False Positives | 0 | 0% | 0 out of 11 |
Statistics for the Plotted Points |
DIAZINON, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 2 | 71% | 19% | 71% | 20% |
Total | 2 | 71% | 19% | 71% | 20% |
Miscellaneous Statistics for the Samples |
DIAZINON, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 2 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 6% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 2 | . | |
False Negatives | 0 | 0% | 0 out of 2 |
Not Spiked | 14 | . | |
False Positives | 0 | 0% | 0 out of 13 |
Statistics for the Plotted Points |
ETHION MONOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 64% | 8% | 64% | 9% |
>= Reporting Level | 26 | 68% | 27% | 64% | 21% |
Total | 28 | 68% | 26% | 64% | 21% |
Miscellaneous Statistics for the Samples |
ETHION MONOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 100% | Spiked |
Estimated Values | 24 | 86% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 28 | . | |
False Negatives | 0 | 0% | 0 out of 28 |
Not Spiked | 41 | . | |
False Positives | 0 | 0% | 0 out of 39 |
Statistics for the Plotted Points |
FENAMIPHOS SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 107% | 22% | 97% | 30% |
>= Reporting Level | 27 | 58% | 28% | 49% | 20% |
Total | 30 | 63% | 30% | 55% | 31% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 100% | Spiked |
Estimated Values | 17 | 57% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 0 | 0% | 0 out of 30 |
Not Spiked | 39 | . | |
False Positives | 3 | 8% | 3 out of 37 |
Statistics for the Plotted Points |
FENAMIPHOS SULFOXIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 87% | 52% | 87% | 55% |
>= Reporting Level | 26 | 44% | 15% | 44% | 16% |
Total | 28 | 47% | 21% | 46% | 16% |
Miscellaneous Statistics for the Samples |
FENAMIPHOS SULFOXIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 74% | Spiked |
Estimated Values | 28 | 74% | Spiked |
Deleted Values | 4 | 6% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 40 | . | |
False Negatives | 9 | 24% | 9 out of 38 |
Not Spiked | 29 | . | |
False Positives | 0 | 0% | 0 out of 27 |
Statistics for the Plotted Points |
FONOFOS, OXYGEN ANALOG |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 3 | 80% | 20% | 89% | 27% |
Total | 3 | 80% | 20% | 89% | 27% |
Miscellaneous Statistics for the Samples |
FONOFOS, OXYGEN ANALOG |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 3 | 100% | Spiked |
Estimated Values | 3 | 100% | Spiked |
Deleted Values | 6 | 17% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 3 | . | |
False Negatives | 0 | 0% | 0 out of 3 |
Not Spiked | 32 | . | |
False Positives | 1 | 4% | 1 out of 26 |
Statistics for the Plotted Points |
MALAOXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 116% | . | 116% | 0% |
>= Reporting Level | 36 | 55% | 28% | 52% | 23% |
Total | 37 | 57% | 30% | 53% | 25% |
Miscellaneous Statistics for the Samples |
MALAOXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 97% | Spiked |
Estimated Values | 8 | 21% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 1 | 3% | 1 out of 38 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 29 |
Statistics for the Plotted Points |
PARAOXON-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 80% | 3% | 81% | 4% |
>= Reporting Level | 28 | 56% | 18% | 54% | 16% |
Total | 31 | 58% | 18% | 57% | 17% |
Miscellaneous Statistics for the Samples |
PARAOXON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 100% | Spiked |
Estimated Values | 31 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 38 | . | |
False Positives | 0 | 0% | 0 out of 36 |
Statistics for the Plotted Points |
PHORATE OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 72% | 25% | 69% | 30% |
>= Reporting Level | 11 | 79% | 26% | 81% | 30% |
Total | 17 | 76% | 25% | 81% | 29% |
Miscellaneous Statistics for the Samples |
PHORATE OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 17 | 100% | Spiked |
Estimated Values | 17 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 17 | . | |
False Negatives | 0 | 0% | 0 out of 17 |
Not Spiked | 52 | . | |
False Positives | 0 | 0% | 0 out of 50 |
Statistics for the Plotted Points |
PHOSMET OXON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 42% | 7% | 43% | 11% |
>= Reporting Level | 6 | 27% | 14% | 24% | 17% |
Total | 9 | 32% | 14% | 34% | 14% |
Miscellaneous Statistics for the Samples |
PHOSMET OXON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 9 | 64% | Spiked |
Estimated Values | 9 | 64% | Spiked |
Deleted Values | 19 | 28% | Spiked + Not Spiked |
Spiked, Censored | 1 | 7% | Spiked |
Spiked | 16 | . | |
False Negatives | 4 | 29% | 4 out of 14 |
Not Spiked | 53 | . | |
False Positives | 0 | 0% | 0 out of 36 |
Statistics for the Plotted Points |
TERBUFOS-O-ANALOGUE SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 76% | 33% | 77% | 49% |
>= Reporting Level | 12 | 70% | 28% | 73% | 34% |
Total | 15 | 71% | 28% | 74% | 41% |
Miscellaneous Statistics for the Samples |
TERBUFOS-O-ANALOGUE SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 15 | 94% | Spiked |
Estimated Values | 12 | 75% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 16 | . | |
False Negatives | 1 | 6% | 1 out of 16 |
Not Spiked | 53 | . | |
False Positives | 0 | 0% | 0 out of 51 |
Statistics for the Plotted Points |
FIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 43 | 88% | 22% | 85% | 22% |
Total | 43 | 88% | 22% | 85% | 22% |
Miscellaneous Statistics for the Samples |
FIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 100% | Spiked |
Estimated Values | 42 | 98% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 25 | . | |
False Positives | 0 | 0% | 0 out of 24 |
Statistics for the Plotted Points |
FIPRONIL SULFIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 16 | 91% | 17% | 93% | 12% |
Total | 16 | 91% | 17% | 93% | 12% |
Miscellaneous Statistics for the Samples |
FIPRONIL SULFIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 16 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 16 | . | |
False Negatives | 0 | 0% | 0 out of 16 |
Not Spiked | 53 | . | |
False Positives | 14 | 27% | 14 out of 51 |
Statistics for the Plotted Points |
FIPRONIL SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 29 | 75% | 20% | 73% | 14% |
Total | 29 | 75% | 20% | 73% | 14% |
Miscellaneous Statistics for the Samples |
FIPRONIL SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 29 | 100% | Spiked |
Estimated Values | 3 | 10% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 0 | 0% | 0 out of 29 |
Not Spiked | 39 | . | |
False Positives | 4 | 11% | 4 out of 38 |
Statistics for the Plotted Points |
DESULFINYLFIPRONIL AMIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 99% | 6% | 100% | 9% |
>= Reporting Level | 11 | 77% | 21% | 74% | 22% |
Total | 14 | 82% | 21% | 80% | 22% |
Miscellaneous Statistics for the Samples |
DESULFINYLFIPRONIL AMIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 14 | 100% | Spiked |
Estimated Values | 14 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 14 | . | |
False Negatives | 0 | 0% | 0 out of 14 |
Not Spiked | 55 | . | |
False Positives | 0 | 0% | 0 out of 53 |
Statistics for the Plotted Points |
DESULFINYLFIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 29 | 85% | 20% | 83% | 21% |
Total | 29 | 85% | 20% | 83% | 21% |
Miscellaneous Statistics for the Samples |
DESULFINYLFIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 29 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 30 | . | |
False Negatives | 0 | 0% | 0 out of 29 |
Not Spiked | 39 | . | |
False Positives | 1 | 3% | 1 out of 38 |
Statistics for the Plotted Points |
ETHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 81% | 20% | 80% | 21% |
Total | 31 | 81% | 20% | 80% | 21% |
Miscellaneous Statistics for the Samples |
ETHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 37 | . | |
False Positives | 0 | 0% | 0 out of 36 |
Statistics for the Plotted Points |
METRIBUZIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 47 | 74% | 16% | 77% | 19% |
Total | 47 | 74% | 16% | 77% | 19% |
Miscellaneous Statistics for the Samples |
METRIBUZIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 47 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 48 | . | |
False Negatives | 0 | 0% | 0 out of 47 |
Not Spiked | 21 | . | |
False Positives | 0 | 0% | 0 out of 20 |
Statistics for the Plotted Points |
2,6-DIETHYLANILINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 92% | 9% | 93% | 6% |
Total | 31 | 92% | 9% | 93% | 6% |
Miscellaneous Statistics for the Samples |
2,6-DIETHYLANILINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 38 | . | |
False Positives | 2 | 6% | 2 out of 36 |
Statistics for the Plotted Points |
TRIFLURALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 78% | 16% | 77% | 12% |
Total | 44 | 78% | 16% | 77% | 12% |
Miscellaneous Statistics for the Samples |
TRIFLURALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 24 | . | |
False Positives | 0 | 0% | 0 out of 23 |
Statistics for the Plotted Points |
DIMETHOATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 25% | 8% | 24% | 7% |
Total | 44 | 25% | 8% | 24% | 7% |
Miscellaneous Statistics for the Samples |
DIMETHOATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 44 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 24 | . | |
False Positives | 0 | 0% | 0 out of 23 |
Statistics for the Plotted Points |
PHORATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 92% | 1% | 92% | 1% |
>= Reporting Level | 30 | 56% | 24% | 59% | 33% |
Total | 32 | 58% | 25% | 61% | 31% |
Miscellaneous Statistics for the Samples |
PHORATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 6 | 19% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 36 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
PARATHION-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 73% | 16% | 71% | 16% |
Total | 32 | 73% | 16% | 71% | 16% |
Miscellaneous Statistics for the Samples |
PARATHION-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 36 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
TEBUTHIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 119% | 38% | 118% | 39% |
Total | 39 | 119% | 38% | 118% | 39% |
Miscellaneous Statistics for the Samples |
TEBUTHIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 100% | Spiked |
Estimated Values | 7 | 18% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 39 |
Not Spiked | 29 | . | |
False Positives | 0 | 0% | 0 out of 28 |
Statistics for the Plotted Points |
BENFLURALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 63% | 18% | 61% | 16% |
Total | 31 | 63% | 18% | 61% | 16% |
Miscellaneous Statistics for the Samples |
BENFLURALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 38 | . | |
False Positives | 0 | 0% | 0 out of 36 |
Statistics for the Plotted Points |
TERBUFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 76% | 27% | 73% | 28% |
Total | 32 | 76% | 27% | 73% | 28% |
Miscellaneous Statistics for the Samples |
TERBUFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 6 | 19% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 36 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
PROPYZAMIDE (PRONAMIDE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 90% | 14% | 93% | 12% |
Total | 32 | 90% | 14% | 93% | 12% |
Miscellaneous Statistics for the Samples |
PROPYZAMIDE (PRONAMIDE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 36 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
CARBARYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 70% | 32% | 62% | 47% |
>= Reporting Level | 41 | 75% | 27% | 75% | 31% |
Total | 44 | 75% | 27% | 75% | 33% |
Miscellaneous Statistics for the Samples |
CARBARYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 98% | Spiked |
Estimated Values | 44 | 98% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 47 | . | |
False Negatives | 1 | 2% | 1 out of 45 |
Not Spiked | 22 | . | |
False Positives | 0 | 0% | 0 out of 22 |
Statistics for the Plotted Points |
DACTHAL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 106% | 12% | 108% | 7% |
Total | 40 | 106% | 12% | 108% | 7% |
Miscellaneous Statistics for the Samples |
DACTHAL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 28 | . | |
False Positives | 0 | 0% | 0 out of 27 |
Statistics for the Plotted Points |
PENDIMETHALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 43 | 86% | 18% | 87% | 15% |
Total | 43 | 86% | 18% | 87% | 15% |
Miscellaneous Statistics for the Samples |
PENDIMETHALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 100% | Spiked |
Estimated Values | 2 | 5% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 43 |
Not Spiked | 25 | . | |
False Positives | 0 | 0% | 0 out of 24 |
Statistics for the Plotted Points |
AZINPHOS-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 85% | 20% | 95% | 24% |
>= Reporting Level | 30 | 65% | 16% | 63% | 15% |
Total | 35 | 68% | 18% | 65% | 17% |
Miscellaneous Statistics for the Samples |
AZINPHOS-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 35 | 100% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 33 | . | |
False Positives | 0 | 0% | 0 out of 32 |